1. Targeted and untargeted serum NMR metabolomics to reveal initial kidney disease in diabetes mellitus.
- Author
-
Lucio-Gutiérrez JR, Cordero-Pérez P, Ávila-Velázquez JL, Torres-González L, Farías-Navarro IC, Govea-Torres G, Sánchez-Martínez C, García-Hernández PA, Coello-Bonilla J, Pérez-Trujillo M, Parella T, Waksman-Minsky NH, and Saucedo AL
- Subjects
- Humans, Male, Middle Aged, Female, Aged, Diabetic Nephropathies blood, Diabetic Nephropathies metabolism, Diabetic Nephropathies diagnosis, Magnetic Resonance Spectroscopy methods, Adult, Prospective Studies, Proton Magnetic Resonance Spectroscopy methods, Metabolomics methods, Diabetes Mellitus, Type 2 blood, Diabetes Mellitus, Type 2 metabolism, Renal Insufficiency, Chronic blood, Renal Insufficiency, Chronic metabolism, Biomarkers blood, Creatinine blood
- Abstract
Serum
1 H NMR metabolomics has been used as a diagnostic tool for screening type 2 diabetes (T2D) with chronic kidney disease (CKD) as comorbidity. This work aimed to evaluate1 H NMR data to detect the initial kidney damage and CKD in T2D subjects, through multivariate statistical analysis. Clinical data and biochemical parameters were obtained for classifying five experimental groups using KDIGO guidelines: Control (healthy subjects), T2D, T2D-CKD-mild, T2D-CKD-moderate, and T2D-CKD-severe. Serum1 H NMR spectra were recorded to follow two strategies: one based on metabolite-to-creatinine (Met/Cr) ratios as targeted metabolomics, and the second one based on untargeted metabolomics from the1 H NMR profile. A prospective biomarkers panel of the early stage of T2D-CKD based in metabolite-to-creatinine ratio (ornithine/Cr, serine/Cr, mannose/Cr, acetate/Cr, acetoacetate/Cr, formate/Cr, and glutamate/Cr) was proposed. Later, a statistical model based on non-targeted metabolomics was used to predict initial CKD, and its metabolic pathway analysis allowed identifying the most affected pathways: phenylalanine, tyrosine, and tryptophan biosynthesis; valine, leucine, and isoleucine degradation; glyoxylate and dicarboxylate metabolism; glycine, serine, and threonine metabolism; and histidine metabolism. Nonetheless, further studies with a larger cohort are advised to precise ranges in metabolite-to-creatinine ratios and evaluate the prediction pertinency to detect initial CKD in T2D patients in both statistical models proposed., Competing Interests: Declaration of Competing Interest Alma L. Saucedo reports financial support was provided by National Council for Science and Technology. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF